 | • レポートコード：MRC23Q38320 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥406,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥812,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のプロプラノロール市場について調査・分析し、世界のプロプラノロール市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（経口、注射）、用途別セグメント分析（不整脈、高血圧、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Apotex、Teva、Atnas Pharma、AstraZeneca、Mylan、Novartis、Sanofi、Yabang Pharma、Sawai Seiyaku、ABZ-Pharma、Towa Yakuhin、Zydus Pharma、Nichi-Iko Pharmaceutical、Intas Pharma、IFET、Iqfarma、Zentivaなどが含まれています。世界のプロプラノロール市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、プロプラノロール市場規模を推定する際に考慮しました。本レポートは、プロプラノロールの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、プロプラノロールに関するビジネス上の意思決定に役立てることを目的としています。 ・プロプラノロール市場の概要 - 製品の定義 - プロプラノロールのタイプ別セグメント - 世界のプロプラノロール市場規模：タイプ別分析（経口、注射） - プロプラノロールの用途別セグメント - 世界のプロプラノロール市場規模：用途別分析（不整脈、高血圧、その他） - 世界のプロプラノロール市場規模予測（2018年-2029年） - プロプラノロールの平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - プロプラノロール市場の競争状況およびトレンド ・プロプラノロールの地域別市場規模 - 北米のプロプラノロール市場規模（2018年-2029年） - アメリカのプロプラノロール市場規模（2018年-2029年） - ヨーロッパのプロプラノロール市場規模（2018年-2029年） - アジア太平洋のプロプラノロール市場規模（2018年-2029年） - 中国のプロプラノロール市場規模（2018年-2029年） - 日本のプロプラノロール市場規模（2018年-2029年） - 韓国のプロプラノロール市場規模（2018年-2029年） - インドのプロプラノロール市場規模（2018年-2029年） - オーストラリアのプロプラノロール市場規模（2018年-2029年） - 中南米のプロプラノロール市場規模（2018年-2029年） - 中東・アフリカのプロプラノロール市場規模（2018年-2029年） ・タイプ別セグメント：経口、注射 - 世界のプロプラノロールのタイプ別販売量（2018年-2023年） - 世界のプロプラノロールのタイプ別売上（2018年-2023年） - 世界のプロプラノロールのタイプ別価格 ・用途別セグメント：不整脈、高血圧、その他 - 世界のプロプラノロールの用途別販売量（2018年-2023年） - 世界のプロプラノロールの用途別売上（2018年-2023年） - 世界のプロプラノロールの用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Apotex、Teva、Atnas Pharma、AstraZeneca、Mylan、Novartis、Sanofi、Yabang Pharma、Sawai Seiyaku、ABZ-Pharma、Towa Yakuhin、Zydus Pharma、Nichi-Iko Pharmaceutical、Intas Pharma、IFET、Iqfarma、Zentiva ・産業チェーンと販売チャネルの分析 - プロプラノロール産業チェーン分析 - プロプラノロールの主要原材料 - プロプラノロールの販売チャネル - プロプラノロールのディストリビューター - プロプラノロールの主要顧客 ・プロプラノロール市場ダイナミクス - プロプラノロールの業界動向 - プロプラノロール市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Propranolol, sold under the brand name Inderal among others, is a medication of the beta blocker class. It is used to treat high blood pressure, a number of types of irregular heart rate, thyrotoxicosis, capillary hemangiomas, performance anxiety, and essential tremors. It is used to prevent migraine headaches, and to prevent further heart problems in those with angina or previous heart attacks. It can be taken by mouth or by injection into a vein.
Highlights
The global Propranolol market was valued at US$ 386 million in 2022 and is anticipated to reach US$ 477.8 million by 2029, witnessing a CAGR of 3.1% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Global Propranolol key players include Apotex, Teva, Atnas Pharma, AstraZeneca, Mylan, etc. Global top five manufacturers hold a share over 28%.
Europe is the largest market, with a share about 30%, followed by North America, and Asia-Pacific, both have a share about 44 percent.
In terms of product, Oral is the largest segment, with a share over 98%. And in terms of application, the largest application is Arrhythmia, followed by Hypertension, and Others.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Propranolol, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Propranolol.
The Propranolol market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Propranolol market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Propranolol manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Apotex
Teva
Atnas Pharma
AstraZeneca
Mylan
Novartis
Sanofi
Yabang Pharma
Sawai Seiyaku
ABZ-Pharma
Towa Yakuhin
Zydus Pharma
Nichi-Iko Pharmaceutical
Intas Pharma
IFET
Iqfarma
Zentiva
Segment by Type
Oral
Injection
Segment by Application
Arrhythmia
Hypertension
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Propranolol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Propranolol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Propranolol market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Propranolol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Propranolol and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Propranolol industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Propranolol.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Propranolol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Propranolol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.
1 Propranolol Market Overview
1.1 Product Overview and Scope of Propranolol
1.2 Propranolol Segment by Type
1.2.1 Global Propranolol Market Value Comparison by Type (2023-2029)
1.2.2 Oral
1.2.3 Injection
1.3 Propranolol Segment by Application
1.3.1 Global Propranolol Market Value by Application: (2023-2029)
1.3.2 Arrhythmia
1.3.3 Hypertension
1.3.4 Others
1.4 Global Propranolol Market Size Estimates and Forecasts
1.4.1 Global Propranolol Revenue 2018-2029
1.4.2 Global Propranolol Sales 2018-2029
1.4.3 Global Propranolol Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Propranolol Market Competition by Manufacturers
2.1 Global Propranolol Sales Market Share by Manufacturers (2018-2023)
2.2 Global Propranolol Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Propranolol Average Price by Manufacturers (2018-2023)
2.4 Global Propranolol Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Propranolol, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Propranolol, Product Type & Application
2.7 Propranolol Market Competitive Situation and Trends
2.7.1 Propranolol Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Propranolol Players Market Share by Revenue
2.7.3 Global Propranolol Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Propranolol Retrospective Market Scenario by Region
3.1 Global Propranolol Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Propranolol Global Propranolol Sales by Region: 2018-2029
3.2.1 Global Propranolol Sales by Region: 2018-2023
3.2.2 Global Propranolol Sales by Region: 2024-2029
3.3 Global Propranolol Global Propranolol Revenue by Region: 2018-2029
3.3.1 Global Propranolol Revenue by Region: 2018-2023
3.3.2 Global Propranolol Revenue by Region: 2024-2029
3.4 North America Propranolol Market Facts & Figures by Country
3.4.1 North America Propranolol Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Propranolol Sales by Country (2018-2029)
3.4.3 North America Propranolol Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Propranolol Market Facts & Figures by Country
3.5.1 Europe Propranolol Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Propranolol Sales by Country (2018-2029)
3.5.3 Europe Propranolol Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Propranolol Market Facts & Figures by Country
3.6.1 Asia Pacific Propranolol Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Propranolol Sales by Country (2018-2029)
3.6.3 Asia Pacific Propranolol Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Propranolol Market Facts & Figures by Country
3.7.1 Latin America Propranolol Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Propranolol Sales by Country (2018-2029)
3.7.3 Latin America Propranolol Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Propranolol Market Facts & Figures by Country
3.8.1 Middle East and Africa Propranolol Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Propranolol Sales by Country (2018-2029)
3.8.3 Middle East and Africa Propranolol Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Propranolol Sales by Type (2018-2029)
4.1.1 Global Propranolol Sales by Type (2018-2023)
4.1.2 Global Propranolol Sales by Type (2024-2029)
4.1.3 Global Propranolol Sales Market Share by Type (2018-2029)
4.2 Global Propranolol Revenue by Type (2018-2029)
4.2.1 Global Propranolol Revenue by Type (2018-2023)
4.2.2 Global Propranolol Revenue by Type (2024-2029)
4.2.3 Global Propranolol Revenue Market Share by Type (2018-2029)
4.3 Global Propranolol Price by Type (2018-2029)
5 Segment by Application
5.1 Global Propranolol Sales by Application (2018-2029)
5.1.1 Global Propranolol Sales by Application (2018-2023)
5.1.2 Global Propranolol Sales by Application (2024-2029)
5.1.3 Global Propranolol Sales Market Share by Application (2018-2029)
5.2 Global Propranolol Revenue by Application (2018-2029)
5.2.1 Global Propranolol Revenue by Application (2018-2023)
5.2.2 Global Propranolol Revenue by Application (2024-2029)
5.2.3 Global Propranolol Revenue Market Share by Application (2018-2029)
5.3 Global Propranolol Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Apotex
6.1.1 Apotex Corporation Information
6.1.2 Apotex Description and Business Overview
6.1.3 Apotex Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Apotex Propranolol Product Portfolio
6.1.5 Apotex Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Teva Propranolol Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Atnas Pharma
6.3.1 Atnas Pharma Corporation Information
6.3.2 Atnas Pharma Description and Business Overview
6.3.3 Atnas Pharma Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Atnas Pharma Propranolol Product Portfolio
6.3.5 Atnas Pharma Recent Developments/Updates
6.4 AstraZeneca
6.4.1 AstraZeneca Corporation Information
6.4.2 AstraZeneca Description and Business Overview
6.4.3 AstraZeneca Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.4.4 AstraZeneca Propranolol Product Portfolio
6.4.5 AstraZeneca Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Mylan Propranolol Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Novartis Propranolol Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sanofi Propranolol Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Yabang Pharma
6.8.1 Yabang Pharma Corporation Information
6.8.2 Yabang Pharma Description and Business Overview
6.8.3 Yabang Pharma Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Yabang Pharma Propranolol Product Portfolio
6.8.5 Yabang Pharma Recent Developments/Updates
6.9 Sawai Seiyaku
6.9.1 Sawai Seiyaku Corporation Information
6.9.2 Sawai Seiyaku Description and Business Overview
6.9.3 Sawai Seiyaku Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Sawai Seiyaku Propranolol Product Portfolio
6.9.5 Sawai Seiyaku Recent Developments/Updates
6.10 ABZ-Pharma
6.10.1 ABZ-Pharma Corporation Information
6.10.2 ABZ-Pharma Description and Business Overview
6.10.3 ABZ-Pharma Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.10.4 ABZ-Pharma Propranolol Product Portfolio
6.10.5 ABZ-Pharma Recent Developments/Updates
6.11 Towa Yakuhin
6.11.1 Towa Yakuhin Corporation Information
6.11.2 Towa Yakuhin Propranolol Description and Business Overview
6.11.3 Towa Yakuhin Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Towa Yakuhin Propranolol Product Portfolio
6.11.5 Towa Yakuhin Recent Developments/Updates
6.12 Zydus Pharma
6.12.1 Zydus Pharma Corporation Information
6.12.2 Zydus Pharma Propranolol Description and Business Overview
6.12.3 Zydus Pharma Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Zydus Pharma Propranolol Product Portfolio
6.12.5 Zydus Pharma Recent Developments/Updates
6.13 Nichi-Iko Pharmaceutical
6.13.1 Nichi-Iko Pharmaceutical Corporation Information
6.13.2 Nichi-Iko Pharmaceutical Propranolol Description and Business Overview
6.13.3 Nichi-Iko Pharmaceutical Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Nichi-Iko Pharmaceutical Propranolol Product Portfolio
6.13.5 Nichi-Iko Pharmaceutical Recent Developments/Updates
6.14 Intas Pharma
6.14.1 Intas Pharma Corporation Information
6.14.2 Intas Pharma Propranolol Description and Business Overview
6.14.3 Intas Pharma Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Intas Pharma Propranolol Product Portfolio
6.14.5 Intas Pharma Recent Developments/Updates
6.15 IFET
6.15.1 IFET Corporation Information
6.15.2 IFET Propranolol Description and Business Overview
6.15.3 IFET Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.15.4 IFET Propranolol Product Portfolio
6.15.5 IFET Recent Developments/Updates
6.16 Iqfarma
6.16.1 Iqfarma Corporation Information
6.16.2 Iqfarma Propranolol Description and Business Overview
6.16.3 Iqfarma Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Iqfarma Propranolol Product Portfolio
6.16.5 Iqfarma Recent Developments/Updates
6.17 Zentiva
6.17.1 Zentiva Corporation Information
6.17.2 Zentiva Propranolol Description and Business Overview
6.17.3 Zentiva Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Zentiva Propranolol Product Portfolio
6.17.5 Zentiva Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Propranolol Industry Chain Analysis
7.2 Propranolol Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Propranolol Production Mode & Process
7.4 Propranolol Sales and Marketing
7.4.1 Propranolol Sales Channels
7.4.2 Propranolol Distributors
7.5 Propranolol Customers
8 Propranolol Market Dynamics
8.1 Propranolol Industry Trends
8.2 Propranolol Market Drivers
8.3 Propranolol Market Challenges
8.4 Propranolol Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer